Are There Risks With Estrace?

Specific Precautions and Warnings for Estrace

Some of the warnings and precautions to be aware of prior to using Estrace include the following:
  • Studies have shown that estrogen hormone replacement therapy (such as Estrace) increases the risk of strokes and blood clots in the legs. Estrace should never be used to prevent heart disease (see Hormone Replacement Therapy and Heart Health for more information), as it is not effective for this use.
  • Before you take Estrace, your healthcare provider should make sure that you are appropriately treated for any risk factors for blood clots or heart disease (such as high blood pressure, high cholesterol, diabetes, obesity, or smoking).
  • For women who still have a uterus (who have not had a hysterectomy), taking Estrace by itself (without a progestin) increases the risk of endometrial cancer (cancer of the lining of the uterus). Women who still have a uterus should take Estrace with a progestin medication.
  • Let your healthcare provider know if you have abnormal vaginal bleeding (such as very heavy bleeding or bleeding between periods) while taking Estrace, as this may be a sign of precancerous or cancerous changes in the uterus. Your healthcare provider can perform the necessary tests to rule out cancer.
  • When possible, Estrace should be stopped four to six weeks before many surgeries, in order to help prevent blood clots.
  • Estrogen drugs (such as Estrace) used with or without a progestin may increase the risk of breast cancer. Proper screening and monitoring (as determined by your healthcare provider), such as yearly mammograms and monthly self breast exams, are recommended.
  • Estrogen drugs (such as Estrace) used with or without a progestin seem to increase the risk of dementia. In no case should Estrace be used to prevent or treat dementia (it is not effective for this use).
  • Women who take estrogen (such as Estrace) have an increased risk for gallbladder disease.
  • Let your healthcare provider know right away if you notice any vision changes. This can signal a blood clot in the retina, a possible side effect of Estrace.
  • Estrace can cause high blood pressure (hypertension) or high triglycerides in some women. Your healthcare provider should monitor you for these problems.
  • If you have had jaundice (yellowing of the whites of the eyes or skin) due to estrogens or pregnancy in the past, it is possible that Estrace will cause similar problems to recur. If this happens, your healthcare provider will probably advise you to stop taking Estrace.
  • If you have an underactive thyroid (hypothyroidism), Estrace may increase your body's requirement for thyroid hormones. Your healthcare provider should monitor you and adjust the dose of your thyroid medication as necessary.
  • Estrace can cause fluid retention. This can cause problems for people with congestive heart failure (CHF) or kidney problems.
  • Estrace should be used with caution in people who have low calcium levels in the blood (known medically as hypocalcemia).
  • It is not clear if Estrace increases the risk of ovarian cancer. Some studies have shown an increased risk, while others have not.
  • Estrace can make endometriosis symptoms worse.
  • Estrace can interact with a number of different medications (see Estrace Drug Interactions for more information).
  • Estrace should not be used during pregnancy (see Estrace and Pregnancy).
  • Estrace does pass through breast milk. Therefore, if you are breastfeeding or plan to start breastfeeding, discuss this with your healthcare provider prior to taking the drug (see Estrace and Breastfeeding).
Osteoporosis: Muscle Strengthening

Estrace Tablet Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.